Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Indivior Pharmaceuticals, Inc.
| Metric | Indivior Pharmaceuticals, Inc. INDVHealthcare |
|---|---|
| Quality Score | 49 / 100 |
| Revenue (latest) | $1.24B |
| Net income (latest) | $210M |
| Operating margin | 21.1% |
| Net margin | 16.9% |
| Return on equity | −214.3% |
| Return on assets | 17.5% |
| Return on capital (ROCE) | 91.3% |
| Debt / equity | — |
| Revenue growth (YoY) | 4.3% |
| Altman Z″ (distress) | -0.70 |
| Accruals / assets | 19.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.